Acute infectious diseases of the respiratory tract are regularly associated with increased concentrations of neopterin in serum and/or urine. Most likely, the pteridine compound is not only a marker of an activated cellular immune system but may exert distinct biochemical functions in the process of infections as well. In response to viral contact, macrophages located in the nasal mucosa may represent a source for neopterin in the nasal cavity with potential hazardous effects on ciliary beat frequency (CBF), thus promoting chronic infectious processes. The aim of the present study was to investigate the effects of neopterin at different concentrations (10 nM, 100 nM, and 100 µM) on CBF in human nasal epithelial cells in vitro. Samples were taken from the inferior nasal turbinate and incubated with neopterin dissolved in either aqua destillata or in sodium chloride (0.9%) at the given amounts for 2, 5, 10, and 20 min. In a preliminary set of experiments, neopterin inhibited CBF following the 5 and 10 min. incubation protocol, respectively. However, analyses of pooled data from 28 experiments using sodium chloride (0.9%) as solvent could not confirm these findings: in no setting a significant reduction of CBF was detected at the end of the 20 min. experimental procedure. Therefore, we conclude that neopterin most likely does not affect the mucociliary clearance defense mechanisms in the course of infections of the nasal respiratory tract.
Introduction
Neopterin is a pyrazino-pyrimidine compound that belongs to the group of unconjugated pteridines synthesized by the conversion of guanosine triphosphate. In ex vivo-studies using peripheral T-lymphocytes, stimulation with growth factors or alloantigens resulted in an augmented neopterin secretion (1, 2) , implying that an activation of the cellular immune system is a prerequisite for its production in humans. Due to its stability in biological fluids, neopterin has become a useful tool to assess the intensity of the TH1-type cell-mediated immune response. Numerous studies have been performed that established neopterin as an indicator for the onset, the progression, and the outcome of the corresponding disease. Thus, correlations between neopterin levels and the state of disease were reported for multiple sclerosis (3), rheumatic fever (4), coeliac disease (5) or systemic lupus erythematosus (6) . In addition, high neopterin concentrations in serum and urine have been reported to be a reliable indicator for the severity of infectious diseases (viral, bacterial, protozoic, parasitic, or fungi-induced infections) as well (7) (8) (9) (10) . The specific nature of neopterin biosynthesis in human monocytes/macrophages signifies that neopterin is not only a marker for an activated cellular (= Th1-type) immune response but might interfere with biochemical mechanisms in the course of the host-defense reaction. Most studies dealing with potential effects of neopterin provided evidence that interactions with reactive oxygen intermediates, and the promotion of oxidative stress is a fundamental principle of the mode of operation of neopterin (11) .
Within this context, neopterin may be regarded as a mediator in the course of infectious diseases and the regularly observed high correlations between neopterin increase and the severity of an infection might be self-explanatory. Moreover, it seems reasonable to speculate that neopterin not only affects biochemical parameters but physiological functions as well. In the nasal tract, the effectiveness of mucociliary clearance is predominantly given by ciliary beat frequency (CBF). Any disturbances in mucociliary clearance can lead to recurrent sinusitis potentially evolving into chronic rhinosinusitis, bronchitis, and otitis media (12) (13) (14) . Elevated circulating levels of neopterin were found in patients with acute respiratory tract infections (15) and in ambulatory volunteers recruited within 24 h of developing symptoms of common cold (16) . In response to viral contact, macrophages located in the nasal mucosa may represent a source for neopterin producing the pteridine in amounts sufficient to exert detrimental effects by directly interfering with epithelial cells within the vicinity of the nasal turbinate. However, to our knowledge, the potential influence of neopterin on CBF has not been investigated to date. Thus, it was the aim of the present study to evaluate the effects of neopterin in different concentrations (10 nM, 100 nM, 100 µM) on CBF in human nasal epithelial cells in vitro.
Materials and Methods

Reagents
In our experiments, neopterin (purchased from Schircks Laboratories, Jona, Switzerland) was applied in concentrations of 10 nM, 100 nM and 100 µM dissolved in aqua destillata or in sodium chloride (NaCl), 0.9%. To avoid chemical and light-induced degradation, neopterin solutions were freshly made prior to every set of experiments.
Nasal brushings
All samples were taken from the inferior nasal turbinate randomly. For a preliminary set of experiments, samples from 2 healthy volunteers (1 male, 1 female) were collected with a cytology brush; The side from which the sample was chosen for the tests was randomly determined. Immediately after removing the brush, each sample was prepared by rolling the brush with moderate pressure across the object slide. The samples were then covered with 0.9% saline, and the CBF was immediately determined. After thoroughly removing the saline from the slide, the samples were gently covered with 100 µl of neopterin diluted to a final concentration of 10 nM, 100 nM, and 100 µM either in aqua destillata or in NaCl (0.9%); subsequently, the CBF was measured again after 2, 5, 10 and 20 min. For the measurement of CBF, a site with a high ciliary beating activity was detected under the microscope and determined as a region of interest. The same site was always recorded before and after application of the test solution. At least 10 single analyses were performed for every concentration of neopterin used in the study. To evaluate the viability of the samples during the preliminary experiments, the epithelial cells on the slide were covered with NaCl (0.9%) and after 20 min the CBF was determined. As expected 0.9% NaCl showed no significant influence on CBF.
In a next set of experiments, another 18 analyses were performed for each concentration of neopterin using specimens taken from samples of 3 additional volunteers (2 male, 1 female) plus the aforementioned male participant. Therefore, in total, a pooled data set was created representing 28 single analyses for each concentration of the pteridine compound taken from samples of 5 study participants (3 male, 2 female). In contrast to the preliminary experiments, only NaCl (0.9%) was used as a solvent for the realization of the pooled data experiments. For the assessment of the viability of the samples for the pooled data, brushings of the inferior nasal turbinate of healthy subjects were covered with NaCl (0.9%) and after 20 min the CBF was determined. After complete removal of the solvent from the samples, the cells were incubated with 100 µl of neopterin diluted to a final concentration of 10 nM, 100 nM, and 100 µM in NaCl (0.9%) and the CBF was measured again after 2, 5, 10 and 20 min as described above.
CBF measurement
The determination of CBF was done by digital highspeed imaging, as described in the literature (17, 18) . First an area of beating cells is selected, which is defined as all pixels for which the standard deviation of the intensity variation over time exceeds a threshold value of 5 dB. A CBF value is computed locally for each pixel separately by spectral analysis of the variation of the pixel intensity over time. For each pixel in the region of interest, the influence of noise on the CBF computation is reduced by spatial averaging of the intensity signal at each time point within a 3x3 pixel region centered around that pixel. Fast Fourier transformation (FFT) analysis is then computed as the frequency corresponding to the maximal FFT amplitude value in the range 0-20 Hz. The analysis method was implemented in Matlab (The Mathworks Inc., Natick, MA) and a graphical user interface was developed for CBF measurement and histogram analysis, which allows deriving overall statistics (mean, standard deviation and median) for the CBF of all beating Neopterin 100 µ µM cilia in the image. The selected area does not correspond to a given number of cells, but to an area where ciliary activity is observed by the computer program. A semi-automated inverse Leica DMI 4000 B research microscope was used. For image acquisition, the microscope is connected to a Redlake high speed video camera (Redlake MASC Inc., San Diego, CA). At a frame rate of 512 frames per second, the images were captured with a sampling interval of 2 ms. A sequence of 1024 images was recorded for each area. Each sequence of frame-by-frame images was stored in a file folder containing 1024 TIF format files for later analysis. The combination of hardware and analysis software offers an automated method for assessment of ciliary beat frequency. All experiments were performed at a constant temperature of 22°C and at a magnification of 400 times.
Statistical analyses
A non-parametric Friedman's ANOVA was applied for the assessment of time dependencies. In case of a significant overall effect, paired Wilcoxon test was applied to assess the significance of changes in parameters of each time point as compared to baseline. A p value below 0.05 was considered as statistically significant. Data in tables and figures are given as mean values ± SEM.
Results
Preliminary experiments
Results of exposure to neopterin at final concentrations of 10 nM, 100 nM and 100 µM, respectively are summarized in Figures 1A-C: for neopterin 10 nM diluted in either aqua destillata or in NaCl (0.9%), a significant drop in CBF was measured after 5 and 10 min (neopterin in aqua destillata) and after 2, 5 and 10 min for neopterin in NaCl (0.9%) (Fig. 1A) . In order to test a possible influence of the diluent per se, the Wilcoxon-test was applied for paired tests at corresponding time points (2, 5, 10 and 20 min; neopterin in aqua destillata vs. NaCl (0.9%)). The CBF was significantly more reduced after 20 min in the neopterin specimen diluted with NaCl (0.9%) as compared to aqua destillata. CBF was significantly decreased following incubation of epithelial cells with 100 nM of neopterin dissolved in aqua destillata but not in NaCl (0.9%) (Fig. 1B) . With respect to the highest concentration of neopterin used in the study (i.e. 100 µM), significant drops in CBF were found following a 2, 5, and 10 min incubation period using aqua destillata as a solvent, and following a 5 and 10 min treatment with NaCl (0.9%) as a solvent (Fig. 1C) . No differences in CBF between aqua destillata and NaCl (0.9%) were found for both 100 nM and 100 µM of neopterin. For all three applied concentrations of neopterin there was no difference in CBF after 20 min as compared to baseline.
Pooled data
For all further experiments shown, neopterin was dissolved in NaCl (0.9%) only. For control of viability, human nasal epithelial cells were incubated with NaCl (0.9%) at those days when the neopterin experiments were performed. Incubation with NaCl (0.9%) alone resulted in no significant time dependent effect after 20 min (pooled data of 28 experiments at baseline: 5.54 ± 0.31 Hz). Fig. 2 A-C shows the pooled data of 28 experiments with neopterin at final concentrations of 10 nM, 100 nM and 100 µM. With the exception of a significant reduction in CBF after 2 min with 100 µM (Fig. 2C ) neopterin did not influence CBF at any time point or at any concentration given suggesting that there is neither a time-dependency nor a dose-response relation for neopterin with respect to CBF.
Discussion
The aim of the present study was to investigate the effects of different concentrations of the pteridine compound neopterin on ciliary beat activity in human nasal epithelial cells in vitro. Increased levels of neopterin are a common finding in the course of infectious diseases (7) (8) (9) (10) . Due to its stability in biological fluids such as serum or urine, neopterin has become a valuable diagnostic tool to assess the intensity of the cell-mediated immune response, e.g. in blood and organ donor screenings (19) Recent findings indicate that neopterin may be a part of the inflammatory arsenal of the body in response to infectious stimuli. Among other effects, neopterin was found to trigger inducible nitric oxide synthesis gene expression and nitric oxide release in vascular smooth muscle cells (VSMC) (20, 21) , to stimulate the generation of the pro-inflammatory cytokine tumor necrosis factor-α in VSMC (22) , or to induce apoptotic cell death in VSMC and the alveolar type II-like epithelial cell line L2 (23, 24) . Most of these observations are based on long-term effects of neopterin requiring 12-24 h of incubation time. However, neopterin was shown to inhibit ATPinduced calcium transients in L2 cells (25) . Since ATP evokes a high calcium release within seconds, these data indicate that neopterin exerts immediate actions as well.
To date, there is no direct evidence for an increased synthesis of neopterin within the nasal cavity. However, it seems reasonable to speculate that macrophages triggered to the nasal mucosa following viral infections are a sufficient source for this pteridine. In addition, epithelial cells themselves may release neopterin following exposure to proper stimuli. At least kidney epithelial cells were shown to secrete neopterin upon incubation with interferon-γ when given as a single stimulus or in combination with tumor necrosis factor-α (26) . Since elevated amounts of serum neopterin were reported in patients with acute respiratory tract infections, we speculated that the pteridine compound might be involved in short-term inflammatory events taking place in the surroundings of the nasal mucosa, thus affecting mucociliary clearance. Any disturbance of CBF may result in recurrent episodes of acute infectious processes and may finally lead to permanent events such as chronic rhinosinusitis, otitis media, and bronchitis (12) (13) (14) . To date, there is no established practical approach to evaluate CBF in vivo. Therefore, we tested the effects of neopterin in an in vitro setting using human nasal epithelial cells freshly taken from the inferior nasal turbinate by cytology brush. In a preliminary set of experiments, neopterin was found to inhibit CBF in a time-dependent fashion with the strongest impact following a 5 and 10 minute incubation period. With respect to the solvents used in our study, we cannot exclude an independent mechanism of aqua destillata on CBF due to its potential hypo-osmotic effect on the epithelial cells. Thus, we decided to use NaCl (0.9%) as a dilutent for neopterin in the next set of experiments.
Although we could detect a tendency towards a decrease in CBF with the most pronounced changes following neopterin given at the highest concentration of 100 µM, incubation of nasal epithelial cells did not result in a significant drop in CBF anymore when pooled data of 28 experiments were analyzed. The significant decrease in CBF found after a 2 minutes incubation with neopterin (100 µM) might be explained by an artificial alteration of cellular behaviour due to a transient mechanical stimulation by adding the incubation media that was not effective anymore following the longer incubation periods. We cannot offer a conclusive explanation for the differences between the preliminary and the pooled data within the first 10 min of our experiments. However, after 20 min exposure of the nasal epithelial cells with neopterin (10 nM, 100 nM, 100 µM) no reduction of CBF was detected. One limitation of this study is the fact that due to the experimental setup a data acquisition beyond 20 min exposure of the cells with neopterin is not possible. Thus, a subacute or chronic effect of neopterin on CBF can not be excluded. Another potential limitation is the use of neopterin in concentrations much higher than those detected in serum and urine in the course of infectious diseases. However, plasma values do not mandatorily reflect the concentration of pteridine compounds within the tissues, where a constant supply of stimuli may result in a continuous production and release of neopterin. Moreover, cell to cell interactions may lead to a local accumulation of neopterin in the cellular microenvironment.
Taken together, these results do not provide evidence for a deleterious effect of neopterin on ciliary beat frequency. Thus, the pteridine compound most likely does not interfere with the mucociliary clearance defense mechanism in the course of infectious diseases of the nasal respiratory tract.
